PROGNOSTIC RELEVANCE OF SERUM HYALURONAN LEVELS IN PATIENTS WITH BREAST-CANCER

被引：18
|
作者：
PONTING, J
HOWELL, A
PYE, D
KUMAR, S
机构：
[1] CHRISTIE HOSP, DEPT MED ONCOL, CRC DEPT MED, MANCHESTER M28 9BX, ENGLAND
[2] CHRISTIE HOSP, DEPT CLIN RES, MANCHESTER M28 9BX, ENGLAND
来源：
INTERNATIONAL JOURNAL OF CANCER | 1992年 / 52卷 / 06期
关键词：
D O I：
10.1002/ijc.2910520607
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The serum hyaluronan (HA) level of 238 women with breast cancer was measured by means of a specific radiometric assay. The results show no significant increase in serum HA when compared to levels in 120 control sera. A number of prognostic factors were evaluated including stage of disease, lymph-node involvement, tumour size, histology and presence of oestrogen and progesterone receptors in the tumour. No correlation was found with serum HA concentration and we conclude that serum HA level is of no prognostic significance in breast cancer.
引用
收藏
页码：873 / 876
页数：4
相关论文
共 50 条
  • [21] PROGNOSTIC RELEVANCE OF RECEPTOR STATUS AND PROLIFERATIVE ACTIVITY IN NODE NEGATIVE BREAST-CANCER PATIENTS
    DIFRONZO, G
    CORADINI, D
    CAPPELLETTI, V
    SCAVONE, GF
    DAIDONE, MG
    SILVESTRINI, R
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1987, : 129 - 129
  • [22] PROGNOSTIC RELEVANCE OF POST-IRRIDATION LYMPHOCYTE-REACTIVITY IN BREAST-CANCER PATIENTS
    WASSERMAN, J
    WALLGREN, A
    BLOMGREN, H
    BARAL, E
    PETRINI, B
    CANCER, 1986, 58 (02) : 348 - 351
  • [23] PROGNOSTIC RELEVANCE OF CARCINOEMBRYONIC ANTIGEN AND ESTROGEN-RECEPTOR STATUS IN BREAST-CANCER PATIENTS
    ESTEBAN, JM
    FELDER, B
    AHN, C
    SIMPSON, JF
    BATTIFORA, H
    SHIVELY, JE
    CANCER, 1994, 74 (05) : 1575 - 1583
  • [24] ASSESSMENT OF THE PROGNOSTIC RELEVANCE OF PGR IN ADDITION TO ER IN NODE NEGATIVE BREAST-CANCER PATIENTS
    CORADINI, D
    SCAVONE, GF
    CAPPELLETTI, V
    MIODINI, P
    GRANATA, G
    DIFRONZO, G
    ANTICANCER RESEARCH, 1986, 6 (03) : 373 - 373
  • [25] SERUM DEOXYRIBONUCLEASES IN PATIENTS WITH BREAST-CANCER
    SPANDIDOS, DA
    RAMANDANIS, G
    GARAS, J
    KOTTARIDIS, SD
    EUROPEAN JOURNAL OF CANCER, 1980, 16 (12) : 1615 - 1619
  • [26] PROGNOSTIC VALUE OF CEA IN BREAST-CANCER PATIENTS
    MYERS, RE
    SUTHERLAND, DJA
    MEAKIN, W
    MALKIN, DG
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1978, 19 (MAR): : 148 - 148
  • [27] STUDY OF SERUM BETA-2 MICROGLOBULIN LEVELS IN BREAST-CANCER PATIENTS
    PAPAIOANNOU, D
    GEGGIE, P
    KLASSEN, J
    CLINICA CHIMICA ACTA, 1979, 99 (01) : 37 - 41
  • [28] EVALUATION OF CA15/3 SERUM LEVELS IN BREAST-CANCER PATIENTS
    GION, M
    MIONE, R
    DITTADI, R
    FASAN, S
    PALLINI, A
    BRUSCAGNIN, G
    JOURNAL OF NUCLEAR MEDICINE AND ALLIED SCIENCES, 1986, 30 (01): : 29 - 36
  • [29] SERUM LEVELS OF THE CA-15-3 ANTIGEN IN PATIENTS WITH BREAST-CANCER
    UGOLOTTI, G
    FRANCHINI, D
    BONELLI, P
    ANGHINONI, E
    MONICI, L
    DELISI, V
    TUMORI, 1986, 72 (06) : 735 - 735
  • [30] SERUM LEVELS OF CA-15.3 IN CLINICAL MANAGEMENT OF PATIENTS WITH BREAST-CANCER
    MOLINA, R
    BALLESTA, AM
    CASALS, E
    MARIN, JL
    GUAL, J
    ELENA, M
    BALAGUE, A
    TUMOUR BIOLOGY, 1985, 6 (04): : 349 - 349
12345